SCHEMBL8772183

SCHEMBL8772183

CCCCCCCC[C@H](O)/C=C/c1cccc(C(=O)c2cc(C(=O)OC)cc(C(=O)OC)c2)n1

nearest known ligand 0.55

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
LTB4R Q15722 6/20 0.55
ALDH1A1 P00352 2/20 0.39
NFKB1 P19838 2/20 0.39
MTOR P42345 1/20 0.39
PMP22 Q01453 1/20 0.39
SMN1; SMN2 Q16637 1/20 0.39
CYP3A4 P08684 1/20 0.39
CYP2C9 P11712 1/20 0.39
ALOX15 P16050 1/20 0.39
KDM4E B2RXH2 1/20 0.39
PLIN1 O60240 1/20 0.39
GAA P10253 1/20 0.39
MAPT P10636 1/20 0.39
MAPK1 P28482 1/20 0.39
PLIN5 Q00G26 1/20 0.39
ABHD5 Q8WTS1 1/20 0.39
NFKB2 Q00653 1/20 0.37
RELA Q04206 1/20 0.37
PPARG P37231 1/20 0.36
PPARA Q07869 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8772187 1.00 LTB4R (0.55) LTB4RALDH1A1NFKB1MTORPMP22
SCHEMBL8772169 1.00 LTB4R (0.55) LTB4RALDH1A1NFKB1MTORPMP22
SCHEMBL8772186 0.95 LTB4R (0.56) LTB4RALDH1A1NFKB1MTORPMP22
SCHEMBL8772190 0.95 LTB4R (0.56) LTB4RALDH1A1NFKB1MTORPMP22
SCHEMBL8772178 0.95 LTB4R (0.56) LTB4RALDH1A1NFKB1MTORPMP22
SCHEMBL8772196 0.89 LTB4R (0.65) LTB4RALDH1A1NFKB1MTORPMP22
SCHEMBL8772179 0.89 LTB4R (0.65) LTB4RALDH1A1NFKB1MTORPMP22
SCHEMBL8772202 0.89 LTB4R (0.65) LTB4RALDH1A1NFKB1MTORPMP22
SCHEMBL8772225 0.86 LTB4R (0.69) LTB4RALDH1A1NFKB1MTORPMP22
SCHEMBL8772230 0.86 LTB4R (0.69) LTB4RALDH1A1NFKB1MTORPMP22

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0801061-A2 Leucotrien-B4 derivatives, process for their preparation and their use as medicaments SCHERING AKTIENGESELLSCHAFT (DE) 1997-10-15 EP disclosed
US-5614634-A Leukotriene-B4 derivatives, process for their production and their use as pharmaceutical agents SCHERING AKTIENGESELLSCHAFT (DE) 1997-03-25 US disclosed
US-5440044-A Leukotriene-B4 derivatives, process for their production and their use as pharmaceutical agents SCHERING AKTIENGESELLSCHAFT (DE) 1995-08-08 US disclosed
EP-0477311-A1 NEW LEUCOTRIENE B 4? DERIVATIVES, METHODS OF PREPARING THEM AND THEIR USE AS DRUGS SCHERING AKTIENGESELLSCHAFT (DE) 1992-04-01 EP disclosed
WO-1991014676-A1 NEW LEUCOTRIENE B4 DERIVATIVES, METHODS OF PREPARING THEM AND THEIR USE AS DRUGS SCHERING AKTIENGESELLSCHAFT BERLIN UND BERGKAMEN (DE) 1991-10-03 WO disclosed